Develop novel glaucoma treatment devices in order to improve treatment efficacy and reduce complications

Glaucoma is a complicated disease and current treatment options are far from optimal as many patients suffer significant vision loss even after multiple surgical operations. At Rheon Medical, we are a strong team devoted to use our strong engineering core to develop novel technologies that can improve treatment efficacy for glaucoma patients and therefore improve their quality of life.
Rheon Medical is a spin-off from the Swiss Institue of Technology in Lausanne (EPFL), one of the strongest polytechnic schools in Europe. Concealed by a management board with strong experience in ophthalmology, our team aspires to become a global leader in the glaucoma device market.